Sign inJoin waitlistJoin the waitlist

MK

Mark Knapp

Physician · American Oncology Network

Credentials: · · · ·

History

American Oncology Network
Present

Hematology and Medical Oncology
University of Cincinnati
2000–2003
Internal Medicine
St Vincent Hospital
1997–2000
University of Cincinnati College of Medicine
1993–1997

Research

Ibrutinib plus lenalidomide and rituximab has promising activity in relapsed/refractory non-germinal center B-cell-like DLBCL
Blood · 2019 · 115 citations
Multicenter randomized phase II study of weekly or twice-weekly bortezomib plus rituximab in patients with relapsed or refractory follicular or marginal-zone B-cell lymphoma
Journal of Clinical Oncology · 2009 · 79 citations
SWOG S1400B (NCT02785913), a Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study)
Journal of Thoracic Oncology · 2019 · 72 citations

Andre Goy
2 papers
DB
Darrin Beaupre
2 papers
Sven de Vos
2 papers
TP
Taral Patel
2 papers
AJ
Abdul Rahman Jazieh
1 paper
AB
Anthony Boral
1 paper
CH
Charles Holladay
1 paper
CS
Charles Shapiro
1 paper
Charu Aggarwal
1 paper
Christopher Flowers
1 paper
Corey Langer
1 paper
DF
Daniel Flora
1 paper · 1 as a resident